Medivir Balance Sheet Health

Financial Health criteria checks 4/6

Medivir has a total shareholder equity of SEK141.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK204.2M and SEK62.4M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 92.50m
EquitySEK 141.80m
Total liabilitiesSEK 62.40m
Total assetsSEK 204.20m

Recent financial health updates

Recent updates

Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Nov 09
Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Jul 27
Is Medivir (STO:MVIR) In A Good Position To Invest In Growth?

Is Medivir (STO:MVIR B) In A Good Position To Deliver On Growth Plans?

Jan 09
Is Medivir (STO:MVIR B) In A Good Position To Deliver On Growth Plans?

Financial Position Analysis

Short Term Liabilities: MVIR's short term assets (SEK97.5M) exceed its short term liabilities (SEK52.9M).

Long Term Liabilities: MVIR's short term assets (SEK97.5M) exceed its long term liabilities (SEK9.5M).


Debt to Equity History and Analysis

Debt Level: MVIR is debt free.

Reducing Debt: MVIR had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MVIR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MVIR has less than a year of cash runway if free cash flow continues to grow at historical rates of 27.7% each year.


Discover healthy companies